Archive: News
-
A Proclamation on National Colorectal Cancer Awareness Month, 2022
“During National Colorectal Cancer Awareness Month, I urge every American to exercise vigilance around their own health and the health of their loved ones. Early diagnosis and treatment save lives — and getting screened for colorectal cancer is vitally important as we continue our shared mission to end cancer as we know it.” President Biden
Category: News
-
Liza and John Marshall- Discuss “Off Our Chests”
After Liza Alexander Marshall’s triple-negative breast cancer diagnosis, her oncologist husband had to shift perspective from doctor to caregiver.
Category: News
-
Biomarkers in GI Cancer
Watch this on-demand webcast from a live satellite symposium covering the latest in biomarker testing and the use of targeted therapeutics in gastrointestinal cancers.
Category: News
-
Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies
For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to Dr. Emil Cohen
Category: News
-
Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer
Dr. Benjamin Weinberg and GI team members including Dr. Winslow and Dr. Bayasi, recently published this case: in which a patient with stage IIA colorectal cancer may have had his life saved by ctDNA .
Category: News
-
John Marshall and his wife Liza discuss book in Costa Rica
John Marshall and his wife Liza are in the country presenting their book “off our chests” where they relate their experience when facing breast cancer, in a discussion organized by the Cancer Center and Hematology of the Metropolitan Hospital.
Category: News
-
The Importance of Neuroendocrine Tumor Imaging
Dr. Giuseppe Esposito, chief of nuclear medicine and professor of radiobiology at MedStar Georgetown, presented on the management of imaging neuroendocrine tumors at the 12th Annual Ruesch Center Symposium.
Category: News
-
Dr. Marshall on the Potential Utility of Trastuzumab Deruxtecan in HER2+ Gastric Cancer
John L. Marshall, MD, discusses the potential utility of fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-positive gastric cancer.
Category: News
-
Dr. Marshall on the Results of the DESTINY-Gastric02 Trial in Gastric/GEJ Cancer
John L. Marshall, MD, discusses the results of the phase 2 DESTINY-Gastric02 trial (NCT04014075) in HER2-positive gastric and gastroesophageal junction (GEJ) cancers.
Category: News
-
Early Onset Colorectal Cancer: Why Is This Happening?
“When I started practice nearly 30 years ago, there was no one in my clinic with colon cancer under the age of 50. But a little over 10 years ago, I started noticing more and more younger people coming in with CRC,” recalls John Marshall, MD
Category: News